| Code | Description | Claims | Beneficiaries | Total Paid |
| T1015 |
Clinic visit/encounter, all-inclusive |
39,260 |
37,189 |
$5.91M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
31,395 |
29,547 |
$1.62M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,266 |
3,031 |
$161K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
2,980 |
2,845 |
$142K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
944 |
915 |
$63K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,103 |
1,068 |
$41K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
292 |
282 |
$2K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
14 |
13 |
$1K |
| 90686 |
|
92 |
88 |
$1K |
| 90756 |
|
28 |
27 |
$502.58 |
| Q3014 |
Telehealth originating site facility fee |
30 |
27 |
$447.78 |
| 90688 |
|
29 |
28 |
$369.86 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
41 |
38 |
$270.97 |
| 93248 |
|
12 |
12 |
$195.36 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12 |
12 |
$97.78 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
13 |
13 |
$0.70 |
| 99406 |
|
13 |
12 |
$0.00 |